Ownership and next steps
Can the site see who owns each new referral, its current status, and the next action?
Enrollment Operations Insight
Before You Buy More Referrals, Look at What Happens After Interest Arrives
A site can create demand and still see fewer referrals reach site review than expected. Before adding more volume, look at what is happening with the referrals already in the pathway and what the study’s own data suggests.
Article Introduction
Before spending more on referral generation, a site should understand what the current pathway is doing with the interest it already receives.
Additional volume may be appropriate when candidate supply is genuinely low. It may be less useful when local data already shows unresolved records, repeated re-contact, unclear ownership, incomplete handoffs, or another constraint that additional volume would not address.
A site can create demand and still see fewer referrals reach site review than expected. When that happens, the work after interest arrives is one of the first areas worth examining before adding more volume. That does not prove that part of the process is the cause. Protocol requirements, referral-source mix, candidate circumstances, site capacity, downstream processes, clinical factors, and other study-specific conditions may also matter.
This article focuses on one practical question: what should a site examine before purchasing additional referral generation?
What to Review
Information completeness
Are incomplete records or repeated clarification steps visible in the site’s data?
Follow-up
Can the site see contact attempts, permitted channels, unresolved records, and closure status?
Handoff
Does the site know how often a handoff requires reconstruction or additional clarification?
Where the Workflow Can Be Examined
Patient Interest
Is there a defined next operational step when interest arrives?
Referral Intake
Are required operational and candidate-reported fields captured consistently, and are unresolved items visible?
Preliminary Prescreening
Are site-approved preliminary questions, candidate-reported responses, and unresolved items documented consistently without making eligibility decisions?
Referral Handoff
Does the handoff contain the agreed information needed for site review, or does it frequently require clarification?
Site Review
What information or clarification work occurs after site receipt, and is that work material enough to justify a change?
What Research Teams Should Look At
Can the site see who owns each new referral and what happens next?
Where do records remain unresolved before site review?
How often does incomplete information require re-contact or clarification?
Is intake execution consistent enough to compare across sources, staff, or studies?
How often does the site handoff require reconstruction or additional clarification?
What does the study data suggest should change, if anything: referral generation, the work after interest arrives, both, or something else?
How Consent2Randomize Helps
If the site’s own data points to an issue with the work after interest arrives, Consent2Randomize may support approved post-interest work such as intake, preliminary prescreening, follow-up, scheduling coordination, documentation, escalation, and handoff.
If the study genuinely needs more candidate flow, C2R may support study-approved patient recruitment.
Some studies may need both. The evidence should determine the scope rather than the article assuming the answer in advance.
Formal screening, final eligibility decisions, informed consent, protocol oversight, medical decisions, investigator responsibilities, and randomization remain with the research site.
Review the Workflow in Context
If this question is relevant to your site, start with the related resources above or use the Enrollment Bottleneck Diagnostic to review the workflow using local information.